French launch is latest milestone in roll-out of Sandoz respiratory portfolio – a key pillar of its strategy to bring differentiated generics to patients and payors worldwideMometasone Sandoz® is first French specialty generic medicine indicated for tr…
Princeton, New Jersey, June 3, 2014 – Sandoz today announced an agreement with Upsher-Smith to obtain exclusive US distribution rights for its branded potassium chloride line of products, Klor-Con®, and market them under the Sandoz name, enhancing its …
Holzkirchen, May 15, 2015 – More than 19,000 Novartis associates worldwide volunteer for local causes on Community Partnership DayNovartis associates across 55 countries engaged in local volunteer efforts to support their communities in celebration of …
Holzkirchen, June 4, 2014 – Sandoz, the generic pharmaceuticals division of Novartis, today announced the launch in several European countries of generic escitalopram, an affordable and high-quality version of reference product Cipralex®.The Sandoz pro…
Holzkirchen, June 4, 2014 – Sandoz, the generic pharmaceuticals division of Novartis, today announced the launch in several European countries of generic escitalopram, an affordable and high-quality version of reference product Cipralex®.The Sandoz pro…
Seoul, May 14 2014 – Sandoz Korea announces that it is launching today AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD).The product was first approved in Denmark in December, …
We are pleased that a court in Norway has denied GSK’s request to restrict access to Sandoz’s AirFluSal® Forspiro® in Norway. AirFluSal® Forspiro® provides patients with asthma and/or COPD with an award-winning innovative device for delivering the prov…
Today Sandoz recognizes World Asthma Day. World Asthma Day is an annual event organized by the Global Initiative for Asthma (GINA) with the goal of improving asthma awareness and care around the world. This year’s theme is, “It’s time to control asthma…
Princeton, New Jersey, April 28, 2014 – Sandoz today announced the US market introduction of its adapalene 0.3% gel, a generic version of Galderma Laboratories’ Differin® Gel, 0.3%.Adapalene gel is a retinoid, indicated for the topical treatment of acn…
Princeton, New Jersey, April 28, 2014 – Sandoz today announced the US market introduction of its adapalene 0.3% gel, a generic version of Galderma Laboratories’ Differin® Gel, 0.3%.Adapalene gel is a retinoid, indicated for the topical treatment of acn…